Role of Adrenal Vein Sampling in Guiding Surgical Decision in Primary Aldosteronism

 

 Permissions and Reprints

Abstract

Adrenal vein sampling (AVS) is recommended for subtyping primary aldosteronism (PA) to identify lateralized or bilateral sources of aldosterone excess, allowing for better decision-making in regard to medical or surgical management on a case-by-case basis. To date, no consensus exists on protocols to be used during AVS, especially concerning sampling techniques, the timing of sampling, and whether or not to use adrenocorticotropic hormone (ACTH) stimulation. Interpretation criteria for selectivity, lateralization, and contralateral suppression vary from one expert center to another, with some favoring strict cut-offs to others being more permissive. Clinical and biochemical post-operative outcomes can also be influenced by AVS criteria utilized to indicate surgical therapy.

In this review, we reanalyze studies on AVS highlighting the recent pathological findings of frequent micronodular hyperplasia adjacent to a dominant aldosteronoma (APA) overlapping with bilateral idiopathic hyperaldosteronism (IHA) etiologies, as opposed to the less frequent unilateral single aldosteronoma. The variable expression of melanocortin type 2 receptors in the nodules and hyperplasia may explain the frequent discordance in lateralization ratios between unstimulated and ACTH- stimulated samples. We conclude that aldosterone values collected during simultaneous bilateral sampling, both at baseline and post-ACTH stimulation, are required to adequately evaluate selectivity, lateralization, and contralateral suppression during AVS, to better identify all patients with PA that can benefit from a surgical indication. Recommended cut-offs for each ratio are also presented.

Publication History

Received: 20 December 2022
Received: 24 April 2023

Accepted: 01 June 2023

Article published online:
11 August 2023

© 2023. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

• References

• 1 Turcu AF, Yang J, Vaidya A. Primary aldosteronism — a multidimensional syndrome. Nat Rev Endocrinol 2022; 18: 665-682 DOI: 10.1038/s41574-022-00730-2.
  CrossrefPubMedGoogle Scholar
• 2 Parasiliti-Caprino M, Lopez C, Prencipe N. et al. Prevalence of primary aldosteronism and association with cardiovascular complications in patients with resistant and refractory hypertension. J Hypertens 2020; 38: 1841-1848 DOI: 10.1097/HJH.0000000000002441.
  CrossrefPubMedGoogle Scholar
• 3 Monticone S, D’Ascenzo F, Moretti C. et al. Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: A systematic review and meta-analysis. Lancet Diabetes Endocrinol 2018; 6: 41-50 DOI: 10.1016/S2213-8587(17)30319-4.
  CrossrefPubMedGoogle Scholar
• 4 Funder JW, Carey RM, Mantero F. et al. The management of primary aldosteronism: Case detection, diagnosis, and treatment: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2016; 101: 1889-1916 DOI: 10.1210/jc.2015-4061.
  CrossrefPubMedGoogle Scholar
• 5 Reincke M, Bancos I, Mulatero P. et al. Diagnosis and treatment of primary aldosteronism. Lancet Diabetes Endocrinol 2021; 9: 876-892 DOI: 10.1016/S2213-8587(21)00210-2.
  CrossrefPubMedGoogle Scholar
• 6 Amar L, Baguet JP, Bardet S. et al. SFE/SFHTA/AFCE primary aldosteronism consensus: Introduction and handbook. Ann Endocrinol 2016; 77: 179-186 DOI: 10.1016/j.ando.2016.05.001.
  CrossrefPubMedGoogle Scholar
• 7 Nishikawa T, Omura M, Satoh F. et al. Guidelines for the diagnosis and treatment of primary aldosteronism – the Japan Endocrine Society 2009. Endocr J 2011; 58: 711-721 DOI: 10.1507/endocrj.ej11-0133.
  CrossrefPubMedGoogle Scholar
• 8 Kempers MJE, Lenders JWM, van Outheusden L. et al. Systematic review: Diagnostic procedures to differentiate unilateral from bilateral adrenal abnormality in primary aldosteronism. Ann Intern Med 2009; 151: 329-337 DOI: 10.7326/0003-4819-151-5-200909010-00007.
  CrossrefPubMedGoogle Scholar
• 9 Lim V, Guo Q, Grant CS. et al. Accuracy of adrenal imaging and adrenal venous sampling in predicting surgical cure of primary aldosteronism. J Clin Endocrinol Metab 2014; 99: 2712-2719 DOI: 10.1210/jc.2013-4146.
  CrossrefPubMedGoogle Scholar
• 10 Aono D, Kometani M, Karashima S. et al. Primary aldosteronism subtype discordance between computed tomography and adrenal venous sampling. Hypertens Res Off J Jpn Soc Hypertens 2019; 42: 1942-1950 DOI: 10.1038/s41440-019-0310-y.
  CrossrefPubMedGoogle Scholar
• 11 Wannachalee T, Caoili E, Nanba K. et al The concordance between imaging and adrenal vein sampling varies with aldosterone-driver somatic mutation. J Clin Endocrinol Metab 2020; 105 dgaa482 DOI: 10.1210/clinem/dgaa482.
  CrossrefPubMedGoogle Scholar
• 12 Gkaniatsa E, Sakinis A, Palmér M. et al. Adrenal venous sampling in young patients with primary aldosteronism. extravagance or irreplaceable?. J Clin Endocrinol Metab 2021; 106: e2087-e2095 DOI: 10.1210/clinem/dgab047.
  CrossrefPubMedGoogle Scholar
• 13 Rossi GP, Crimì F, Rossitto G. et al. Feasibility of maging-guided adrenalectomy in young patients with primary aldosteronism. Hypertens Dallas Tex 1979 2022; 79: 187-195 DOI: 10.1161/HYPERTENSIONAHA.121.18284.
  CrossrefPubMedGoogle Scholar
• 14 Nanba K, Baker JE, Blinder AR. et al. Histopathology and genetic causes of primary aldosteronism in young adults. J Clin Endocrinol Metab 2022; 107: 2473-2482 DOI: 10.1210/clinem/dgac408.
  CrossrefPubMedGoogle Scholar
• 15 Matsuura T, Takase K, Ota H. et al. Radiologic anatomy of the right adrenal vein: Preliminary experience with MDCT. AJR Am J Roentgenol 2008; 191: 402-408 DOI: 10.2214/AJR.07.3338.
  CrossrefPubMedGoogle Scholar
• 16 Miotto D, De Toni R, Pitter G. et al. Impact of accessory hepatic veins on adrenal vein sampling for identification of surgically curable primary aldosteronism. Hypertens Dallas Tex 1979 2009; 54: 885-889 DOI: 10.1161/HYPERTENSIONAHA.109.134759.
  CrossrefPubMedGoogle Scholar
• 17 Rossi GP, Auchus RJ, Brown M. et al. An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism. Hypertens Dallas Tex 1979 2014; 63: 151-160 DOI: 10.1161/HYPERTENSIONAHA.113.02097.
  CrossrefPubMedGoogle Scholar
• 18 Monticone S, Viola A, Rossato D. et al. Adrenal vein sampling in primary aldosteronism: Towards a standardised protocol. Lancet Diabetes Endocrinol 2015; 3: 296-303 DOI: 10.1016/S2213-8587(14)70069-5.
  CrossrefPubMedGoogle Scholar
• 19 Yatabe M, Bokuda K, Yamashita K. et al. Cosyntropin stimulation in adrenal vein sampling improves the judgment of successful adrenal vein catheterization and outcome prediction for primary aldosteronism. Hypertens Res Off J Jpn Soc Hypertens 2020; 43: 1105-1112 DOI: 10.1038/s41440-020-0445-x.
  CrossrefPubMedGoogle Scholar
• 20 Rossitto G, Maiolino G, Lenzini L. et al. Subtyping of primary aldosteronism with adrenal vein sampling: Hormone- and side-specific effects of cosyntropin and metoclopramide. Surgery 2018; 163: 789-795 DOI: 10.1016/j.surg.2017.09.032.
  CrossrefPubMedGoogle Scholar
• 21 El Ghorayeb N, Mazzuco TL, Bourdeau I. et al. Basal and post-ACTH aldosterone and its ratios are useful during adrenal vein sampling in primary aldosteronism. J Clin Endocrinol Metab 2016; 101: 1826-1835 DOI: 10.1210/jc.2015-3915.
  CrossrefPubMedGoogle Scholar
• 22 Gomez-Sanchez CE, Qi X, Velarde-Miranda C. et al. Development of monoclonal antibodies against human CYP11B1 and CYP11B2. Mol Cell Endocrinol 2014; 383: 111-117 DOI: 10.1016/j.mce.2013.11.022.
  CrossrefPubMedGoogle Scholar
• 23 Nanba AT, Nanba K, Byrd JB. et al. Discordance between imaging and immunohistochemistry in unilateral primary aldosteronism. Clin Endocrinol (Oxf) 2017; 87: 665-672 DOI: 10.1111/cen.13442.
  CrossrefPubMedGoogle Scholar
• 24 Yamazaki Y, Nakamura Y, Omata K. et al. Histopathological classification of cross-sectional image-negative hyperaldosteronism. J Clin Endocrinol Metab 2017; 102: 1182-1192 DOI: 10.1210/jc.2016-2986.
  CrossrefPubMedGoogle Scholar
• 25 Williams TA, Gomez-Sanchez CE, Rainey WE. et al. International histopathology consensus for unilateral primary aldosteronism. J Clin Endocrinol Metab 2021; 106: 42-54 DOI: 10.1210/clinem/dgaa484.
  CrossrefPubMedGoogle Scholar
• 26 Boulkroun S, Samson-Couterie B, Dzib J-FG. et al. Adrenal cortex remodeling and functional zona glomerulosa hyperplasia in primary aldosteronism. Hypertens Dallas Tex 1979 2010; 56: 885-892 DOI: 10.1161/HYPERTENSIONAHA.110.158543.
  CrossrefPubMedGoogle Scholar
• 27 Hacini I, De Sousa K, Boulkroun S. et al. Somatic mutations in adrenals from patients with primary aldosteronism not cured after adrenalectomy suggest common pathogenic mechanisms between unilateral and bilateral disease. Eur J Endocrinol 2021; 185: 405-412 DOI: 10.1530/EJE-21-0338.
  CrossrefPubMedGoogle Scholar
• 28 Omata K, Satoh F, Morimoto R. et al. Cellular and genetic causes of idiopathic hyperaldosteronism. Hypertens Dallas Tex 1979 2018; 72: 874-880 DOI: 10.1161/HYPERTENSIONAHA.118.11086.
  CrossrefPubMedGoogle Scholar
• 29 Nanba K, Rainey WE. Pathophysiology of bilateral hyperaldosteronism. Curr Opin Endocrinol Diabetes Obes 2022; 29: 233-242 DOI: 10.1097/MED.0000000000000729.
  CrossrefPubMedGoogle Scholar
• 30 Meyer LS, Handgriff L, Lim JS. et al. Single-center prospective cohort study on the histopathology, genotype, and postsurgical outcomes of patients with primary aldosteronism. Hypertens Dallas Tex 1979 2021; 78: 738-746 DOI: 10.1161/HYPERTENSIONAHA.121.17348.
  CrossrefPubMedGoogle Scholar
• 31 Volpe C, Hamberger B, Zedenius J. et al. Impact of immunohistochemistry on the diagnosis and management of primary aldosteronism: An important tool for improved patient follow-up. Scand J Surg SJS Off Organ Finn Surg Soc Scand Surg Soc 2020; 109: 133-142 DOI: 10.1177/1457496918822622.
  CrossrefPubMedGoogle Scholar
• 32 Zwermann O, Suttmann Y, Bidlingmaier M. et al. Screening for membrane hormone receptor expression in primary aldosteronism. Eur J Endocrinol 2009; 160: 443-451 DOI: 10.1530/EJE-08-0711.
  CrossrefPubMedGoogle Scholar
• 33 Rossi GP, Ganzaroli C, Miotto D. et al. Dynamic testing with high-dose adrenocorticotrophic hormone does not improve lateralization of aldosterone oversecretion in primary aldosteronism patients. J Hypertens 2006; 24: 371-379 DOI: 10.1097/01.hjh.0000202818.10459.96.
  CrossrefPubMedGoogle Scholar
• 34 Tanemoto M, Suzuki T, Abe M. et al. Physiologic variance of corticotropin affects diagnosis in adrenal vein sampling. Eur J Endocrinol 2009; 160: 459-463 DOI: 10.1530/EJE-08-0840.
  CrossrefPubMedGoogle Scholar
• 35 Seccia TM, Miotto D, Battistel M. et al. A stress reaction affects assessment of selectivity of adrenal venous sampling and of lateralization of aldosterone excess in primary aldosteronism. Eur J Endocrinol 2012; 166: 869-875 DOI: 10.1530/EJE-11-0972.
  CrossrefPubMedGoogle Scholar
• 36 Rossitto G, Battistel M, Barbiero G. et al. The subtyping of primary aldosteronism by adrenal vein sampling: Sequential blood sampling causes factitious lateralization. J Hypertens 2018; 36: 335-343 DOI: 10.1097/HJH.0000000000001564.
  CrossrefPubMedGoogle Scholar
• 37 Yozamp N, Hundemer GL, Moussa M. et al. Variability of aldosterone measurements during adrenal venous sampling for primary aldosteronism. Am J Hypertens 2021; 34: 34-45 DOI: 10.1093/ajh/hpaa151.
  CrossrefPubMedGoogle Scholar
• 38 Kline GA, Darras P, Leung AA. et al. Surprisingly low aldosterone levels in peripheral veins following intravenous sedation during adrenal vein sampling: implications for the concept of nonsuppressibility in primary aldosteronism. J Hypertens 2019; 37: 596-602 DOI: 10.1097/HJH.0000000000001905.
  CrossrefPubMedGoogle Scholar
• 39 Almarzooqi M-K, Chagnon M, Soulez G. et al. Adrenal vein sampling in primary aldosteronism: Concordance of simultaneous vs sequential sampling. Eur J Endocrinol 2017; 176: 159-167 DOI: 10.1530/EJE-16-0701.
  CrossrefPubMedGoogle Scholar
• 40 Carr CE, Cope C, Cohen DL. et al. Comparison of sequential versus simultaneous methods of adrenal venous sampling. J Vasc Interv Radiol JVIR 2004; 15: 1245-1250 DOI: 10.1097/01.RVI.0000134495.26900.6A.
  CrossrefPubMedGoogle Scholar
• 41 Vonend O, Ockenfels N, Gao X. et al. Adrenal venous sampling: Evaluation of the German Conn’s registry. Hypertens Dallas Tex 1979 2011; 57: 990-995 DOI: 10.1161/HYPERTENSIONAHA.110.168484.
  CrossrefPubMedGoogle Scholar
• 42 Mulatero P, Bertello C, Sukor N. et al. Impact of different diagnostic criteria during adrenal vein sampling on reproducibility of subtype diagnosis in patients with primary aldosteronism. Hypertens Dallas Tex 1979 2010; 55: 667-673 DOI: 10.1161/HYPERTENSIONAHA.109.146613.
  CrossrefPubMedGoogle Scholar
• 43 Mailhot J-P, Traistaru M, Soulez G. et al. Adrenal vein sampling in primary aldosteronism: sensitivity and specificity of basal adrenal vein to peripheral vein cortisol and aldosterone ratios to confirm catheterization of the adrenal vein. Radiology 2015; 277: 887-894 DOI: 10.1148/radiol.2015142413.
  CrossrefPubMedGoogle Scholar
• 44 Turcu AF, Auchus R. Approach to the patient with primary aldosteronism: Utility and limitations of adrenal vein sampling. J Clin Endocrinol Metab 2021; 106: 1195-1208 DOI: 10.1210/clinem/dgaa952.
  CrossrefPubMedGoogle Scholar
• 45 Huang C-W, Lee B-C, Liu K-L. et al. Preoperative non-stimulated adrenal venous sampling index for predicting outcomes of adrenalectomy for unilateral primary aldosteronism. J Formos Med Assoc 2020; 119: 1185-1192 DOI: 10.1016/j.jfma.2020.04.016.
  CrossrefPubMedGoogle Scholar
• 46 Elliott P, Holmes DT. Adrenal vein sampling: Substantial need for technical improvement at regional referral centres. Clin Biochem 2013; 46: 1399-1404 DOI: 10.1016/j.clinbiochem.2013.04.004.
  CrossrefPubMedGoogle Scholar
• 47 Monticone S, Satoh F, Giacchetti G. et al. Effect of adrenocorticotropic hormone stimulation during ddrenal vein sampling in primary aldosteronism. Hypertension 2012; 59: 840-846 DOI: 10.1161/HYPERTENSIONAHA.111.189548.
  CrossrefPubMedGoogle Scholar
• 48 Younes N, Therasse E, Bourdeau I. et al Successful adrenal vein sampling using dexamethasone premedication in patients with iodine contrast media allergy. J Endocr Soc 2022; 6 bvac093 DOI: 10.1210/jendso/bvac093.
  CrossrefPubMedGoogle Scholar
• 49 Hu J, Chen J, Cheng Q. et al. Comparison of bolus and continuous infusion of adrenocorticotropic hormone during adrenal vein sampling. Front Endocrinol 2021; 12: 784706 DOI: 10.3389/fendo.2021.784706.
  CrossrefPubMedGoogle Scholar
• 50 Dekkers T, Prejbisz A, Kool LJS. et al. Adrenal vein sampling versus CT scan to determine treatment in primary aldosteronism: An outcome-based randomised diagnostic trial. Lancet Diabetes Endocrinol 2016; 4: 739-746 DOI: 10.1016/S2213-8587(16)30100-0.
  CrossrefPubMedGoogle Scholar
• 51 Young WF, Stanson AW, Thompson GB. et al. Role for adrenal venous sampling in primary aldosteronism. Surgery 2004; 136: 1227-1235 DOI: 10.1016/j.surg.2004.06.051.
  CrossrefPubMedGoogle Scholar
• 52 Rossi GP, Rossitto G, Amar L. et al. Clinical outcomes of 1625 patients with primary aldosteronism subtyped with adrenal vein sampling. Hypertens Dallas Tex 1979 2019; 74: 800-808 DOI: 10.1161/HYPERTENSIONAHA.119.13463.
  CrossrefPubMedGoogle Scholar
• 53 Benoit J, Gaudissard J, Doublet J. et al. Adrenal BORDeAux reGistry: Bordeaux single-center study of hypertensive patients with primary hyperaldosteronism. J Hypertens 2022; 40: 908-915 DOI: 10.1097/HJH.0000000000003091.
  CrossrefPubMedGoogle Scholar
• 54 Seccia TM, Miotto D, De Toni R. et al. Adrenocorticotropic hormone stimulation during adrenal vein sampling for identifying surgically curable subtypes of primary aldosteronism: Comparison of 3 different protocols. Hypertens Dallas Tex 1979 2009; 53: 761-766 DOI: 10.1161/HYPERTENSIONAHA.108.128553.
  CrossrefPubMedGoogle Scholar
• 55 Deinum J, Groenewoud H, van der Wilt GJ. et al. Adrenal venous sampling: Cosyntropin stimulation or not?. Eur J Endocrinol 2019; 181: D15-D26 DOI: 10.1530/EJE-18-0844.
  CrossrefPubMedGoogle Scholar
• 56 Yozamp N, Hundemer GL, Moussa M. et al. Adrenocorticotropic hormone-stimulated adrenal venous sampling underestimates surgically curable primary aldosteronism: A retrospective cohort study and review of contemporary studies. Hypertens Dallas Tex 1979 2021; 78: 94-103 DOI: 10.1161/HYPERTENSIONAHA.121.17248.
  CrossrefPubMedGoogle Scholar
• 57 Chee NYN, Abdul-Wahab A, Libianto R. et al. Utility of adrenocorticotropic hormone in adrenal vein sampling despite the occurrence of discordant lateralization. Clin Endocrinol (Oxf) 2020; 93: 394-403 DOI: 10.1111/cen.14220.
  CrossrefPubMedGoogle Scholar
• 58 Takeda Y, Umakoshi H, Takeda Y. et al. Impact of adrenocorticotropic hormone stimulation during adrenal venous sampling on outcomes of primary aldosteronism. J Hypertens 2019; 37: 1077-1082 DOI: 10.1097/HJH.0000000000001964.
  CrossrefPubMedGoogle Scholar
• 59 Sung T-Y, Alobuia WM, Tyagi MV. et al. Adrenal vein sampling to distinguish between unilateral and bilateral primary hyperaldosteronism: To ACTH stimulate or not?. J Clin Med 2020; 9: 1447 DOI: 10.3390/jcm9051447.
  CrossrefPubMedGoogle Scholar
• 60 Wolley MJ, Ahmed AH, Gordon RD. et al. Does ACTH improve the diagnostic performance of adrenal vein sampling for subtyping primary aldosteronism?. Clin Endocrinol (Oxf) 2016; 85: 703-709 DOI: 10.1111/cen.13110.
  CrossrefPubMedGoogle Scholar
• 61 Kobayashi H, Nakamura Y, Abe M. et al. Effect of cosyntropin during adrenal venous sampling on subtype of primary aldosteronism: Analysis of surgical outcome. Eur J Endocrinol 2020; 182: 265-273 DOI: 10.1530/EJE-19-0860.
  CrossrefPubMedGoogle Scholar
• 62 Wannachalee T, Zhao L, Nanba K. et al. Three discrete patterns of primary aldosteronism lateralization in response to cosyntropin during adrenal vein sampling. J Clin Endocrinol Metab 2019; 104: 5867-5876 DOI: 10.1210/jc.2019-01182.
  CrossrefPubMedGoogle Scholar
• 63 Violari EG, Arici M, Singh CK. et al. Adrenal vein sampling with and without cosyntropin stimulation for detection of surgically remediable aldosteronism. Endocrinol Diabetes Metab 2019; 2: e00066 DOI: 10.1002/edm2.66.
  CrossrefPubMedGoogle Scholar
• 64 Shibayama Y, Wada N, Naruse M. et al. The occurrence of apparent bilateral aldosterone suppression in adrenal vein sampling for primary aldosteronism. J Endocr Soc 2018; 2: 398-407 DOI: 10.1210/js.2017-00481.
  CrossrefPubMedGoogle Scholar
• 65 Desrochers M-J, St-Jean M, El Ghorayeb N. et al. Basal contralateral aldosterone suppression is rare in lateralized primary aldosteronism. Eur J Endocrinol 2020; 183: 399-409 DOI: 10.1530/EJE-20-0254.
  CrossrefPubMedGoogle Scholar
• 66 Williams TA, Lenders JWM, Mulatero P. et al. Outcomes after adrenalectomy for unilateral primary aldosteronism: An international consensus on outcome measures and analysis of remission rates in an international cohort. Lancet Diabetes Endocrinol 2017; 5: 689-699 DOI: 10.1016/S2213-8587(17)30135-3.
  CrossrefPubMedGoogle Scholar
• 67 Burrello J, Burrello A, Stowasser M. et al. The primary aldosteronism aurgical outcome score for the prediction of clinical outcomes after adrenalectomy for unilateral primary aldosteronism. Ann Surg 2020; 272: 1125-1132 DOI: 10.1097/SLA.0000000000003200.
  CrossrefPubMedGoogle Scholar
• 68 Monticone S, Satoh F, Viola A. et al. Aldosterone suppression on contralateral adrenal during adrenal vein sampling does not predict blood pressure response after adrenalectomy. J Clin Endocrinol Metab 2014; 99: 4158-4166 DOI: 10.1210/jc.2014-2345.
  CrossrefPubMedGoogle Scholar
• 69 Umakoshi H, Tanase-Nakao K, Wada N. et al. Importance of contralateral aldosterone suppression during adrenal vein sampling in the subtype evaluation of primary aldosteronism. Clin Endocrinol (Oxf) 2015; 83: 462-467 DOI: 10.1111/cen.12761.
  CrossrefPubMedGoogle Scholar
• 70 Espiner EA, Ross DG, Yandle TG. et al. Predicting surgically remedial primary aldosteronism: Role of adrenal scanning, posture testing, and adrenal vein sampling. J Clin Endocrinol Metab 2003; 88: 3637-3644 DOI: 10.1210/jc.2002-022051.
  CrossrefPubMedGoogle Scholar
• 71 Doppman JL, Gill JR, Miller DL. et al. Distinction between hyperaldosteronism due to bilateral hyperplasia and unilateral aldosteronoma: Reliability of CT. Radiology 1992; 184: 677-682 DOI: 10.1148/radiology.184.3.1509049.
  CrossrefPubMedGoogle Scholar
• 72 Kline GA, Chin A, So B. et al. Defining contralateral adrenal suppression in primary aldosteronism: Implications for diagnosis and outcome. Clin Endocrinol (Oxf) 2015; 83: 20-27 DOI: 10.1111/cen.12669.
  CrossrefPubMedGoogle Scholar
• 73 Dominguez DA, Chatani P, Murphy R. et al. Contralateral suppression index does not predict clinical cure in patients undergoing surgery for primary aldosteronism. Ann Surg Oncol 2021; 28: 7487-7495 DOI: 10.1245/s10434-021-09692-7.
  CrossrefPubMedGoogle Scholar
• 74 Wolley MJ, Gordon RD, Ahmed AH. et al. Does contralateral suppression at adrenal venous sampling predict outcome following unilateral adrenalectomy for primary aldosteronism? A retrospective study. J Clin Endocrinol Metab 2015; 100: 1477-1484 DOI: 10.1210/jc.2014-3676.
  CrossrefPubMedGoogle Scholar
• 75 Auchus RJ, Wians FH, Anderson ME. et al. What we still do not know about adrenal vein sampling for primary aldosteronism. Horm Metab Res Horm Stoffwechselforschung Horm Metab 2010; 42: 411-415 DOI: 10.1055/s-0030-1252060.
  Article in Thieme ConnectPubMedGoogle Scholar
• 76 Umakoshi H, Tsuiki M, Yokomoto-Umakoshi M. et al. Correlation between lateralization index of adrenal venous sampling and standardized outcome in primary aldosteronism. J Endocr Soc 2018; 2: 893-902 DOI: 10.1210/js.2018-00055.
  CrossrefPubMedGoogle Scholar
• 77 Satani N, Ota H, Seiji K. et al. Intra-adrenal aldosterone secretion: Segmental adrenal venous sampling for localization. Radiology 2016; 278: 265-274 DOI: 10.1148/radiol.2015142159.
  CrossrefPubMedGoogle Scholar
• 78 Kitamoto T, Kitamoto KK, Omura M. et al. Precise mapping of intra-adrenal aldosterone activities provides a vovel surgical strategy for primary aldosteronism. Hypertension 2020; 76: 976-984 DOI: 10.1161/HYPERTENSIONAHA.119.14341.
  CrossrefPubMedGoogle Scholar
• 79 Makita K, Nishimoto K, Kiriyama-Kitamoto K. et al. A novel method: Super-selective adrenal venous sampling. J Vis Exp JoVE 2017; 55716 DOI: 10.3791/55716.
  CrossrefPubMedGoogle Scholar
• 80 Satoh F, Morimoto R, Seiji K. et al. Is there a role for segmental adrenal venous sampling and adrenal sparing surgery in patients with primary aldosteronism?. Eur J Endocrinol 2015; 173: 465-477 DOI: 10.1530/EJE-14-1161.
  CrossrefPubMedGoogle Scholar
• 81 Tannai H, Makita K, Koike Y. et al. Usefulness and accuracy of segmental adrenal venous sampling on localisation and functional diagnosis of various adrenal lesions in primary aldosteronism. Clin Radiol 2022; 77: e652-e659 DOI: 10.1016/j.crad.2022.05.010.
  CrossrefPubMedGoogle Scholar
• 82 Omura M, Saito J, Matsuzawa Y. et al. Supper-selective ACTH-stimulated adrenal vein sampling is necessary for detecting precisely functional state of various lesions in unilateral and bilateral adrenal disorders, inducing primary aldosteronism with subclinical Cushing’s syndrome. Endocr J 2011; 58: 919-920 DOI: 10.1507/endocrj.ej11-0210.
  CrossrefPubMedGoogle Scholar
• 83 Pasternak JD, Epelboym I, Seiser N. et al. Diagnostic utility of data from adrenal venous sampling for primary aldosteronism despite failed cannulation of the right adrenal vein. Surgery 2016; 159: 267-273 DOI: 10.1016/j.surg.2015.06.048.
  CrossrefPubMedGoogle Scholar
• 84 Durivage C, Blanchette R, Soulez G. et al. Adrenal venous sampling in primary aldosteronism: Multinomial regression modeling to detect aldosterone secretion lateralization when right adrenal sampling is missing. J Hypertens 2017; 35: 362-368 DOI: 10.1097/HJH.0000000000001165.
  CrossrefPubMedGoogle Scholar
• 85 Kometani M, Yoneda T, Karashima S. et al. Effect of intraprocedural cortisol measurement on ACTH-stimulated adrenal vein sampling in primary aldosteronism. J Endocr Soc 2022; 6 bvac104 DOI: 10.1210/jendso/bvac104.
  CrossrefPubMedGoogle Scholar
• 86 Peitzsch M, Dekkers T, Haase M. et al. An LC-MS/MS method for steroid profiling during adrenal venous sampling for investigation of primary aldosteronism. J Steroid Biochem Mol Biol 2015; 145: 75-84 DOI: 10.1016/j.jsbmb.2014.10.006.
  CrossrefPubMedGoogle Scholar
• 87 O’Toole SM, Sze W-CC, Chung T-T. et al. Low-grade cortisol cosecretion has limited impact on ACTH-stimulated AVS parameters in primary aldosteronism. J Clin Endocrinol Metab 2020; 105: e3776-e3784 DOI: 10.1210/clinem/dgaa519.
  CrossrefPubMedGoogle Scholar
• 88 Heinrich DA, Quinkler M, Adolf C. et al. Influence of cortisol cosecretion on non-ACTH-stimulated adrenal venous sampling in primary aldosteronism: A retrospective cohort study. Eur J Endocrinol 2022; 187: 637-650 DOI: 10.1530/EJE-21-0541.
  CrossrefPubMedGoogle Scholar
• 89 Ma Y, Chen H, Chen F. et al. Mass spectrometry-based cortisol profiling during adrenal venous sampling reveals misdiagnosis for subtyping primary aldosteronism. Clin Endocrinol (Oxf) 2022; 96: 680-689 DOI: 10.1111/cen.14666.
  CrossrefPubMedGoogle Scholar
• 90 Ceolotto G, Antonelli G, Maiolino G. et al. Androstenedione and 17-α-hydroxyprogesterone are better indicators of adrenal vein sampling selectivity than cortisol. Hypertens Dallas Tex 1979 2017; 70: 342-346 DOI: 10.1161/HYPERTENSIONAHA.117.09415.
  CrossrefPubMedGoogle Scholar
• 91 Liu W, Zhang J, Yang Y. et al. Application of metanephrine and normetanephrine in evaluating the selectivity of adrenal vein sampling. Horm Metab Res Horm Stoffwechselforschung Horm Metab 2022; 54: 162-167 DOI: 10.1055/a-1756-4937.
  Article in Thieme ConnectPubMedGoogle Scholar
• 92 Dekkers T, Deinum J, Schultzekool LJ. et al. Plasma metanephrine for assessing the selectivity of adrenal venous sampling. Hypertens Dallas Tex 1979 2013; 62: 1152-1157 DOI: 10.1161/HYPERTENSIONAHA.113.01601.
  CrossrefPubMedGoogle Scholar
• 93 Christou F, Pivin E, Denys A. et al. Accurate location of catheter tip with the free-to-total metanephrine ratio during adrenal vein sampling. Front Endocrinol 2022; 13: 842968 DOI: 10.3389/fendo.2022.842968.
  CrossrefPubMedGoogle Scholar
• 94 Ceolotto G, Antonelli G, Caroccia B. et al. Comparison of cortisol, androstenedione and metanephrines to assess selectivity and ateralization of adrenal vein sampling in primary aldosteronism. J Clin Med 2021; 10: 4755 DOI: 10.3390/jcm10204755.
  CrossrefPubMedGoogle Scholar
• 95 Dream S, Park S, Yen TW. et al. Utility of epinephrine levels in determining adrenal vein cannulation during adrenal venous sampling for primary aldosteronism. Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol 2022; 28: 276-281 DOI: 10.1016/j.eprac.2021.09.009.
  CrossrefPubMedGoogle Scholar
• 96 DeLozier OM, Dream S, Findling JW. et al. Wide variability in catecholamine levels from adrenal venous sampling in primary aldosteronism. J Surg Res 2022; 277: 1-6 DOI: 10.1016/j.jss.2022.03.016.
  CrossrefPubMedGoogle Scholar
• 97 Bertherat J, Bourdeau I, Bouys L. et al. Clinical, pathophysiologic, genetic and therapeutic progress in primary bilateral macronodular adrenal hyperplasia. Endocr Rev 2022; bnac034 DOI: 10.1210/endrev/bnac034.
  CrossrefPubMedGoogle Scholar
• 98 Williams TA, Gong S, Tsurutani Y. et al. Adrenal surgery for bilateral primary aldosteronism: An international retrospective cohort study. Lancet Diabetes Endocrinol 2022; 10: 769-771 DOI: 10.1016/S2213-8587(22)00253-4.
  CrossrefPubMedGoogle Scholar
• 99 Vaidya A, Mulatero P, Baudrand R. et al. The expanding spectrum of primary aldosteronism: Implications for diagnosis, pathogenesis, and treatment. Endocr Rev 2018; 39: 1057-1088 DOI: 10.1210/er.2018-00139.
  CrossrefPubMedGoogle Scholar
• 100 Williams TA, Reincke M. Management of endocrine disease: Diagnosis and management of primary aldosteronism: the Endocrine Society guideline 2016 revisited. Eur J Endocrinol 2018; 179: R19-R29 DOI: 10.1530/EJE-17-0990.
  CrossrefPubMedGoogle Scholar
• 101 Pedersen M, Karlsen MA, Ankjærgaard KL. et al. Primary hyperaldosteronism diagnosed with adrenal vein sampling. Characteristics and follow-up after adrenalectomy in a Danish study. Scand J Clin Lab Invest 2016; 76: 45-50 DOI: 10.3109/00365513.2015.1092047.
  CrossrefPubMedGoogle Scholar
• 102 Citton M, Viel G, Rossi GP. et al. Outcome of surgical treatment of primary aldosteronism. Langenbecks Arch Surg 2015; 400: 325-331 DOI: 10.1007/s00423-014-1269-4.
  CrossrefPubMedGoogle Scholar
• 103 Haase M, Riester A, Kröpil P. et al. Outcome of adrenal vein sampling performed during concurrent mineralocorticoid receptor antagonist therapy. J Clin Endocrinol Metab 2014; 99: 4397-4402 DOI: 10.1210/jc.2014-2788.
  CrossrefPubMedGoogle Scholar
• 104 Wolley M, Gordon RD, Pimenta E. et al. Repeating adrenal vein sampling when neither aldosterone/cortisol ratio exceeds peripheral yields a high incidence of aldosterone-producing adenoma. J Hypertens 2013; 31: 2005-2009 DOI: 10.1097/HJH.0b013e328362add3.
  CrossrefPubMedGoogle Scholar
• 105 Kline GA, So B, Dias VC. et al. Catheterization during adrenal vein sampling for primary aldosteronism: Failure to use (1–24) ACTH may increase apparent failure rate. J Clin Hypertens 2013; 15: 480-484 DOI: 10.1111/jch.12096.
  CrossrefPubMedGoogle Scholar
• 106 Monticone S, Satoh F, Giacchetti G. et al. Effect of adrenocorticotropic hormone stimulation during adrenal vein sampling in primary aldosteronism. Hypertens Dallas Tex 1979 2012; 59: 840-846 DOI: 10.1161/HYPERTENSIONAHA.111.189548.
  CrossrefPubMedGoogle Scholar
• 107 Webb R, Mathur A, Chang R. et al. What is the best criterion for the interpretation of adrenal vein sample results in patients with primary hyperaldosteronism?. Ann Surg Oncol 2012; 19: 1881-1886 DOI: 10.1245/s10434-011-2121-5.
  CrossrefPubMedGoogle Scholar
• 108 Mathur A, Kemp CD, Dutta U. et al. Consequences of adrenal venous sampling in primary hyperaldosteronism and predictors of unilateral adrenal disease. J Am Coll Surg 2010; 211: 384-390 DOI: 10.1016/j.jamcollsurg.2010.05.006.
  CrossrefPubMedGoogle Scholar